SCYNEXIS, Inc. ( SCYX) - Key Metrics
SCYX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | $0.63 | -$1.26 | -$1.26 |
| 2026Q1 | $0 | -$3.34 | -$1.27 | -$1.27 |
| 2025Q4 | $3.43 | $2.25 | $3.38 | $3.38 |
| 2025Q3 | $0.05 | -$1.38 | -$1.40 | -$1.40 |
| 2025Q2 | $0.22 | -$1.11 | -$1.21 | -$1.21 |
SCYX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 1.62 |
| 2026Q1 | 0% | -0.55 |
| 2025Q4 | 0% | 0.56 |
| 2025Q3 | 0% | -1.12 |
| 2025Q2 | 0% | -1.22 |
SCYX
Price: $3.80
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.89 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 45800
Ebitda: -8.0 millionMarket Capitalization: 30.4 million